Nobel Biocare AG
|
| Company Information |
| Address |
Industriestrasse 9
6010 Kriens |
| Country |
Switzerland |
| Phone |
+41 (0) 41 340 30 40 |
| Internet |
www.nobelbiocare.com |
| Business Sector |
Healthcare/Medical Products |
| Brief Overview |
Nobel Biocare develops, produces, and markets dental implants and IT-based industrialised dental prosthetics. The company operates two business units: Dental implant, which makes permanent replacements for lost teeth, and Procera®, a unique, fully digitized custom-manufacturing and business process of prosthetic components. |
| |
| People |
| Chief Executive Officer |
Heliane Canepa |
| Chief Financial Officer |
Harrieth Sundaeus |
| Chairman of the Board |
Ernst Thomke |
| Auditors |
KPMG Fides |
| No. of Employees |
1328 |
| |
| Going Public |
| Exchange |
Swiss Exchange |
| IPO Date |
June 24, 2002 |
| Share Identification Number |
1403004 |
| Symbol |
NOBE |
| Subscription Period |
01,01,2000 to 01,01,2001
|
| Lead Underwriter |
UBS Warburg |
| Total No. of Shares in Issue after Going Public |
25,347,512 |
| No. of Offered Shares |
25,347,512 |
| Total No. of Issued Share
|
100% |
| First Day Close |
CHF 106 |
| |
|
|
| Last Fiscal Year End Date Prior to Going Public |
December 31, 2001 |
|
Change Compared to Prior Year
|
| Turnover 2001 |
|
| Turnover 2000 |
|
|
Change Compared to Prior Year |
| Operating Profit, EBIT 2001 |
|
| Operating Profit, EBIT 2000 |
|
|
Change Compared to Prior Year |
| Profit Before Tax 2001 |
|
| Profit Before Tax 2000 |
|
|
Change Compared to Prior Year |
| Company Profit 2001 |
|
| Company Profit2000 |
|
| |
|
| Company Profit
2001 reflects |
7.1 % of Turnover |
| Company Profit
2000 reflects |
6.4 % of Turnover
|
| |
|
| Equity on Last Balance Date |
1,934,594 |
| Total Assets |
3,046,042 |
| Ratio of Equity to Total Capital on Balance Date |
63.5 % |
| Last Return on Equity (ROE) |
9.8 % |
| |
| Notes |
The Company's stock is already traded at Stockholmbörsen since 1994. After an upcoming reorganization of the Company, the parent company of the holding will be in Switzerland. Also, the primary listing of the stock will take place at SWX Swiss Exchange.
|